Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity

相似書籍

• Once Daily IV Busulfan and Fludarabine (IV Bu-Flu) Compares Favorably with IV Busulfan and Cyclophosphamide (IV BuCy2) as Pretransplant Conditioning Therapy in AML/MDS
  由: Andersson, Borje S., et al.
  出版: (2008)
• Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
  由: Pidala, Joseph, et al.
  出版: (2011)
• Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT
  由: Dirou, Stéphanie, et al.
  出版: (2014)
• Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
  由: Pidala, Joseph, et al.
  出版: (2010)
• Comparison of Fixed Dose Reduced-Intensity Conditioning with Fludarabine and Busulfan to PK-guided Busulfan AUC (FluBu4K) in Hematopoietic Stem Cell Transplant for AML/MDS
  由: Rasor, Brendan, et al.
  出版: (2020)